OraSure Technologies Revenue 2006-2019 | OSUR
OraSure Technologies revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| OraSure Technologies Annual Revenue (Millions of US $) |
|
|---|---|
| 2018 | $182 |
| 2017 | $167 |
| 2016 | $128 |
| 2015 | $120 |
| 2014 | $106 |
| 2013 | $99 |
| 2012 | $88 |
| 2011 | $82 |
| 2010 | $75 |
| 2009 | $77 |
| 2008 | $71 |
| 2007 | $83 |
| 2006 | $68 |
| 2005 | $69 |
| OraSure Technologies Quarterly Revenue (Millions of US $) |
|
|---|---|
| Q1 2019 | $30 |
| Q4 2018 | $50 |
| Q3 2018 | $46 |
| Q2 2018 | $44 |
| Q1 2018 | $42 |
| Q4 2017 | $52 |
| Q3 2017 | $42 |
| Q2 2017 | $40 |
| Q1 2017 | $33 |
| Q4 2016 | $35 |
| Q3 2016 | $32 |
| Q2 2016 | $31 |
| Q1 2016 | $29 |
| Q4 2015 | $32 |
| Q3 2015 | $30 |
| Q2 2015 | $30 |
| Q1 2015 | $27 |
| Q4 2014 | $29 |
| Q3 2014 | $28 |
| Q2 2014 | $26 |
| Q1 2014 | $24 |
| Q4 2013 | $29 |
| Q3 2013 | $25 |
| Q2 2013 | $24 |
| Q1 2013 | $21 |
| Q4 2012 | $22 |
| Q3 2012 | $22 |
| Q2 2012 | $23 |
| Q1 2012 | $21 |
| Q4 2011 | $24 |
| Q3 2011 | $22 |
| Q2 2011 | $19 |
| Q1 2011 | $17 |
| Q4 2010 | $19 |
| Q3 2010 | $19 |
| Q2 2010 | $19 |
| Q1 2010 | $18 |
| Q4 2009 | $21 |
| Q3 2009 | $22 |
| Q2 2009 | $17 |
| Q1 2009 | $17 |
| Q4 2008 | $17 |
| Q3 2008 | $17 |
| Q2 2008 | $19 |
| Q1 2008 | $18 |
| Q4 2007 | $20 |
| Q3 2007 | $21 |
| Q2 2007 | $21 |
| Q1 2007 | $20 |
| Q4 2006 | $18 |
| Q3 2006 | $18 |
| Q2 2006 | $18 |
| Q1 2006 | $15 |
| Q4 2005 | $18 |
| Q3 2005 | $18 |
| Q2 2005 | $17 |
| Q1 2005 | $16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.529B | $0.182B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $134.025B | 26.02 |
| Medtronic (MDT) | Ireland | $117.659B | 17.20 |
| Stryker (SYK) | United States | $68.704B | 24.52 |
| Boston Scientific (BSX) | United States | $51.899B | 24.88 |
| Baxter (BAX) | United States | $38.763B | 24.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.843B | 15.32 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $18.247B | 0.00 |
| ResMed (RMD) | United States | $16.172B | 30.90 |
| Canopy Growth (CGC) | Canada | $15.352B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.842B | 46.88 |
| Aurora Cannabis (ACB) | Canada | $8.802B | 86.80 |
| Perrigo (PRGO) | Ireland | $6.755B | 11.42 |
| Hill-Rom Holdings (HRC) | United States | $6.504B | 19.72 |
| Insulet (PODD) | United States | $6.200B | 451.74 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.280B | 0.00 |
| Haemonetics (HAE) | United States | $5.104B | 41.87 |
| ICU Medical (ICUI) | United States | $4.630B | 27.62 |
| Hutchison China MediTech (HCM) | China | $3.565B | 0.00 |
| NuVasive (NUVA) | United States | $3.164B | 25.84 |
| Neogen (NEOG) | United States | $3.071B | 49.94 |
| Agios Pharmaceuticals (AGIO) | United States | $2.941B | 0.00 |
| Quidel (QDEL) | United States | $2.233B | 23.17 |
| National Vision Holdings (EYE) | United States | $2.120B | 45.18 |
| Aphria (APHA) | $1.712B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.377B | 790.80 |
| Phibro Animal Health (PAHC) | United States | $1.168B | 17.50 |
| AtriCure (ATRC) | United States | $1.136B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.083B | 22.98 |
| Lantheus Holdings (LNTH) | United States | $0.941B | 25.00 |
| NanoString Technologies (NSTG) | United States | $0.941B | 0.00 |
| Omeros (OMER) | United States | $0.914B | 0.00 |
| MacroGenics (MGNX) | United States | $0.913B | 0.00 |
| PetIQ (PETQ) | United States | $0.806B | 19.58 |
| Cerus (CERS) | United States | $0.754B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.753B | 21.11 |
| TG Therapeutics (TGTX) | United States | $0.609B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.541B | 26.20 |
| Surmodics (SRDX) | United States | $0.527B | 76.59 |
| Quanterix (QTRX) | United States | $0.498B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.462B | 14.13 |
| Evolus (EOLS) | United States | $0.440B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.343B | 107.18 |
| Utah Medical Products (UTMD) | United States | $0.311B | 21.52 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.310B | 0.00 |
| Vapotherm (VAPO) | United States | $0.282B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.267B | 0.00 |
| Zynex (ZYXI) | United States | $0.240B | 24.80 |
| Owens & Minor (OMI) | United States | $0.226B | 4.79 |
| Cytosorbents (CTSO) | United States | $0.223B | 0.00 |
| Bovie Medical (APYX) | United States | $0.204B | 0.00 |
| Chimerix (CMRX) | United States | $0.179B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.134B | 0.00 |
| Fonar (FONR) | United States | $0.134B | 7.05 |
| Surface Oncology (SURF) | United States | $0.111B | 0.00 |
| Female Health (VERU) | United States | $0.103B | 0.00 |
| United-Guardian (UG) | United States | $0.094B | 20.70 |
| Neurotrope (NTRP) | United States | $0.091B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.079B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.058B | 20.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Senestech (SNES) | United States | $0.042B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.032B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.029B | 0.00 |
| BRAINSWAY LTD (BWAY) | Israel | $0.027B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.025B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.011B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.006B | 4.60 |
